Scholars Central

Conference abstractPublished 15 Jul 2013

A herbal compound preparation can affect bone metabolism through multiple biological signals

Authors: Ronghua Zhang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Many of the traditional herbs have been used to treat osteoporosis and other bone diseases in china. We found a Chinese herbal compound preparation (including Epimedii, Medlar, Angelica, Bidentatae, Eucommia and Gentiana) could be effective in the treatment of postmenopausal osteoporosis(PMO) by affecting bone metabolism in multiple biological signals. A clinical trial conducted in a prospective, randomized, double blinded method lasting for 6 months with placebo and positive control indicated that the efficacy and safety in the treatment of PMO, and it also could increase estrogen levels and improve bone structure in ovariectomized rats. We observed the compound preparation could upregulate the expression of bone morphogenetic protein 2(BMP-2), transforming growth factor β1 (TGF-β1), osteoprotegerin (OPG), and insulin-like growth factor I (IGF-I), type I collagen (Col I), osteocalcin, alkaline phosphatase(ALP), Runx2 and adenylate cyclase, inhibit the expression of IL-6, matrix metalloproteinase-1 (MMP-1) in bone tissue, and also regulate neuroskeletal signalling pathways through the influence of the beta2-adrenergic receptor (ADRB2), γ-amino butyric acid (GABA), glutamate, metabotropic glutamate receptor (of mGluR1, mGluR2/3), N-methyl-Daspartate receptor (of NMDAR1) and 5-serotonin transporter (5-HTT). The serum containing ingredients of the compound preparation could affect the differentiation and mineralization of osteoblasts and osteoclasts apoptosis through regulating the signals of estrogen receptor, BMP-2/Smads, nitric oxide synthase/nitric oxide (NOS/NO), OPG/RANKL/RANK, IL-1, IL-6, IGF-I and mitogen-activated protein kinases (MAPK) in vitro. These research results show the network pharmacological mechanisms of the compound preparation for the regulation of bone metabolism through multi-target and multi-link, which is different from the current drugs of affect single bone formation or bone resorption, provide a new choice for the prevention and treatment of osteoporosis and other bone diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Proteomics & Bioinformatics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Ronghua Zhang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels